Congenica contributes to the BIA's Genomics Nation report
Congenica joins the BIA's report looking at the strength, breadth and opportunity of the UK genomics sector for investors, patients and the economy.
Unleash Molecular Superpowers with Next-Generation Genomic Analysis
NGS data analysis software augments molecular medicine powers so more patients can be diagnosed and treated
Discovering Glut1 Deficiency Syndrome
In recognition of the first International Glut1 Awareness Day, guest blogger Trudy Morgan from Glut1 Deficiency UK talks about her experiences.
David Atkins welcomes the Government's Life Sciences Sector Vision
A press release from the UK Bio Industry Association (BIA) welcomes the Government's new Life Sciences Sector Vision and quotes Congenica CEO David Atkins
Rapid diagnosis of Long QT syndrome protects family from major health risk
Congenica supports the rapid diagnosis of Long QT syndrome and enables consideration of potentially life-saving interventions for baby and mother.
Congenica named in UK’s Digital Health Playbook - ‘First 100’ Companies
Congenica has been featured in the UK’s Digital Health Playbook ‘First 100’ as one of the UK’s most innovative and impactful digital health companies.
SCN8A – the needle in the haystack
As part of our Patient Advocacy and Engagement program, we welcome guest blogger Ben Clay, whose daughter Tilly was diagnosed with SCN8A when she was 8.
Exome analysis of cases with skeletal dysplasia
Andrea Haworth at Congenica presented a poster at Rady’s Frontiers in Pediatric Genomic Medicine event that looked at cases of skeletal dysplasia.
Automated variant classification workflows in a rare disease laboratory
Helen Savage presented a poster at Rady’s Frontiers in Pediatric Genomic Medicine highlighting the case for automating standardised analysis of cases.
Redressing the balance: Ring Chromosome 20 Syndrome
Congenica welcomes Allison Watson to talk about her experiences of Ring Chromosome 20 (R(20) - an ultra-rare epilepsy syndrome.